Oppenheimer Reiterates Outperform Rating on AngioDynamics (ANGO)

October 4, 2024 12:15 PM UTC Send to a Friend
Oppenheimer analyst Steven M. Lichtman reiterated an Outperform rating and $13.00 price target on AngioDynamics (NASDAQ: ANGO).The analyst comments "ANGO ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login